Register entry

Corden Pharma International GmbH

Data as of · How to read this entry

Registered sites
4
Active NDC listings
14
Labeller names
2
Live patents
0
Countries
3
Base
Germany
Authorisation

Registered operations

Analytical testing3Active ingredient (API) manufacture2Labelling2Finished drug manufacture2Packaging2
Sites

Registered establishments

4
EstablishmentAddressRegistered forFEI / DUNS
Corden Pharma Switzerland LLCEichenweg 1, Liestal, 4410 CHE, Switzerland (CHE)Analytical testing, Active ingredient (API) manufacture3002561809481829653
Corden Pharma International GmbHAlt-Fechenheim 34, Frankfurt am Main, 60386, Germany (DEU)Active ingredient (API) manufacture3012722976344326935
Corden Pharma GmbHOtto-Hahn-Strasse 1, Plankstadt, Germany 68723, Germany (DEU)Analytical testing, Labelling, Finished drug manufacture, Packaging3007014398341627897
CORDEN PHARMA SPARegistrant: Corden Pharma S.p.A.Viale dell'Industria 3, Caponago, 20867, Italy (ITA)Analytical testing, Labelling, Finished drug manufacture, Packaging3002880938338725627
Catalogue

Drug listings by form and route

14

14 active NDC listings: 14 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 14.

Dosage formNDCs
tablet10
tablet, film coated3
injection, powder, for solution1
RouteNDCs
Labeller name on the listingNDCs
corden pharma gmbh13
corden pharma switzerland llc1
Catalogue

Marketed products

14
BrandGeneric nameForm / routeNDC
-Bicalutamidetablet, film coated43265-7195DRUG FOR FURTHER PROCESSING
-Gemcitabinetablet43265-7749DRUG FOR FURTHER PROCESSING
-Pafolacianine sodiuminjection, powder, for solution65373-5390DRUG FOR FURTHER PROCESSING
-Resmetiromtablet43265-7770DRUG FOR FURTHER PROCESSING
-Resmetiromtablet43265-7771DRUG FOR FURTHER PROCESSING
-Resmetiromtablet43265-7772DRUG FOR FURTHER PROCESSING
-Resmetiromtablet43265-7777DRUG FOR FURTHER PROCESSING
-Resmetiromtablet43265-7778DRUG FOR FURTHER PROCESSING
-Resmetiromtablet43265-7779DRUG FOR FURTHER PROCESSING
-Roflumilasttablet43265-7462DRUG FOR FURTHER PROCESSING
-Roflumilasttablet43265-7463DRUG FOR FURTHER PROCESSING
-Ureatablet43265-7748DRUG FOR FURTHER PROCESSING
-tucatinibtablet, film coated43265-7480DRUG FOR FURTHER PROCESSING
-tucatinibtablet, film coated43265-7481DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

4
Compare

Comparable companies in Germany

Enquiry

Common questions

Is Corden Pharma International GmbH FDA approved?
Corden Pharma International GmbH holds 4 FDA-registered establishments across 3 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Corden Pharma International GmbH's drugs manufactured?
At registered sites in Switzerland, Germany, Italy. The FDA register lists Liestal; Frankfurt am Main; Plankstadt; Caponago. Registered operations: analytical testing, active ingredient (API) manufacture, labelling, finished drug manufacture, packaging.
What drugs does Corden Pharma International GmbH make?
14 products are listed under Corden Pharma International GmbH in the openFDA NDC Directory, most often as tablet; tablet, film coated; injection, powder, for solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.